Abstract
Sleep-Disordered Breathing (SDB) is characterized by repetitive partial or complete upper airway occlusion during sleep with a high prevalence in the general community, and associated with considerable morbidity and mortality. In the US, approximately 12 million people 30 to 60 years of age have SDB, and 38,000 die each year from cardiovascular disease attributed to SDB. Substantial morbidity and economic costs are associated with untreated SDB, including those related to daytime sleepiness and hypertension, and cardiovascular co-morbidity. There is a crucial need to address the public health impact of this common condition, including the extent to which treatment of SDB may modify the course of other chronic health conditions such as cardiovascular disease. The public health impact of SDB in large part relates to the association of SDB with cardiovascular disease, a leading cause of mortality in the U.S. Several large epidemiological studies have clearly demonstrated that individuals with SDB have a higher prevalence of cardiovascular disease after controlling for potential confounders. These data, along with the high prevalence of SDB, support a high population attributable risk, suggesting that a high percentage of cardiovascular morbidity in the population may be due to SDB.
Keywords: Sleep apnea syndromes, cardiovascular disease, inflammation, oxidative stress, hypertension, arrhythmias, congestive heart failure, stroke
Current Respiratory Medicine Reviews
Title: Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Volume: 3 Issue: 4
Author(s): Reena Mehra
Affiliation:
Keywords: Sleep apnea syndromes, cardiovascular disease, inflammation, oxidative stress, hypertension, arrhythmias, congestive heart failure, stroke
Abstract: Sleep-Disordered Breathing (SDB) is characterized by repetitive partial or complete upper airway occlusion during sleep with a high prevalence in the general community, and associated with considerable morbidity and mortality. In the US, approximately 12 million people 30 to 60 years of age have SDB, and 38,000 die each year from cardiovascular disease attributed to SDB. Substantial morbidity and economic costs are associated with untreated SDB, including those related to daytime sleepiness and hypertension, and cardiovascular co-morbidity. There is a crucial need to address the public health impact of this common condition, including the extent to which treatment of SDB may modify the course of other chronic health conditions such as cardiovascular disease. The public health impact of SDB in large part relates to the association of SDB with cardiovascular disease, a leading cause of mortality in the U.S. Several large epidemiological studies have clearly demonstrated that individuals with SDB have a higher prevalence of cardiovascular disease after controlling for potential confounders. These data, along with the high prevalence of SDB, support a high population attributable risk, suggesting that a high percentage of cardiovascular morbidity in the population may be due to SDB.
Export Options
About this article
Cite this article as:
Mehra Reena, Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359959
DOI https://dx.doi.org/10.2174/157339807782359959 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Therapy in Sarcoidosis, the Role of Existing Drugs and Future Medicine
Inflammation & Allergy - Drug Targets (Discontinued) Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides
Current Pharmaceutical Design Editorial (Thematic Issue: The Life Cycle of the Heart Failure Patient)
Current Cardiology Reviews The Renin-Angiotensin Systems: Evolving Pharmacological Perspectives for Cerebroprotection
Current Pharmaceutical Design Immunophilins are Involved in the Altered Platelet Aggregation Observed in Patients with Type 2 Diabetes Mellitus
Current Medicinal Chemistry Protocatechuic Acid Alkyl Esters: Hydrophobicity As a Determinant Factor for Inhibition of NADPH Oxidase
Current Medicinal Chemistry Role of Lysophosphatidylcholine (LPC) in Atherosclerosis
Current Medicinal Chemistry Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials
Current Pharmaceutical Design Disulfide Bridges in Defensins
Current Topics in Medicinal Chemistry Doxycycline Inhibition of Abdominal Aortic Aneurysm Growth - A Systematic Review of the Literature
Current Vascular Pharmacology The Critical Role of Insulin-Like Growth Factor-1 Isoforms in the Physiopathology of Skeletal Muscle
Current Genomics Transient Tachypnea of the Newborn: The Treatment Strategies
Current Pharmaceutical Design Insulin Therapy for Improving Cardiac Surgical Outcomes
Current Drug Targets Chemistry of Plant Dyes: Applications and Environmental Implications of Dyeing Processes
Current Environmental Engineering New Insights into the Mechanisms Underlying Vascular and Cardiac Effects of Urocortin
Current Vascular Pharmacology Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Current Pharmaceutical Design Pleiotropic, Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids
Mini-Reviews in Medicinal Chemistry Meal Replacement Beverage Twice a Day in Overweight and Obese Adults (MDRC2012-001)
Current Nutrition & Food Science Pro Atrial Natriuretic Peptide (1-30) and 6-keto PGF<sub>1α</sub> Activity Affects Na<sup>+</sup> Homeostasis in Non-modulating Hypertension
Current Hypertension Reviews The Assessment of Some Metabolic Markers by Combination of Ursolic Acid Supplementation and Resistance Training in Young Older Obese Women
Endocrine, Metabolic & Immune Disorders - Drug Targets